Ecraid augments its response to the expanding monkeypox outbreak in Europe. These preparations are proportionate to the current perceived risk of this infection for European citizens. Ecraid is now operating in outbreak response mode 3 (response) for adults, and in outbreak response mode 2 (mobilisation) for children, the third and second of three response modes.
The impacts of healthcare professionals being research participants are often neglected. As professionals, they tend to be perceived as ‘immune’ to many negative effects of sharing their experiences. However, in the context of an ongoing global pandemic such as COVID-19, these assumptions can be clearly challenged. In March 2022, the RECOVER Social Science team, together with other collaborators, published a new article that draws on their experiences of conducting single and longitudinal qualitative interviews with Health Care Professionals (HCP) in primary, secondary and tertiary settings during the COVID-19 pandemic in Europe during 2020.
At the beginning of 2022, the SARS-CoV-2 pandemic has not stopped yet. Despite high vaccination coverage, the number of positive cases has reached a record level. In addition, a new SARS-CoV-2 variant has emerged (Omicron variant) with a higher infection rate compared to previous variants. Both of these aspects may have a significant effect on the transmission of SARS-CoV-2 within households. However, the extent of that effect has not yet been quantified. Therefore, a new study to analyse the transmission of SARS-CoV-2 infections within households was launched in January 2022.
RECOVER’s partner ISARIC has recently published a report describing the clinical presentation, treatment and outcome of a cohort of over 700,000 patients with COVID-19, hospitalised between January 2020 and September 2021 in 64 countries throughout the world. This has been possible thanks to 1669 institutions and their clinical teams contributing to ISARIC.
The RECOVER project is proud to promote the Ecraid educational webinar “Clinical case discussion: How clinical trials inform antibiotic stewardship”, organized by ERS with the participation of ESCMID. The webinar will take place on 19 January, 2022 from 13:00–14:30 CET.
Today, RECOVER is supporting the activities linked to World AIDS Day with one of its vital partners, Penta. World AIDS Day is an opportunity for people around the world to unite in the fight against HIV, to show support for people living with HIV, and to commemorate those who have died from an AIDS-related illness. World AIDS Day was founded 33 years ago, in 1988.
On its 10th anniversary, University of Oxford’s ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) demonstrates the crucial role of global preparedness and collaboration for advancing knowledge on infectious disease pandemics.
The ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases is ESCMID’s most prestigious award. For 2020, the ESCMID Executive Committee selected Prof. Herman Goossens as recipient of this prestigious award. Prof. Goossens was given this award in recognition of his important contribution to research and education in the field of clinical microbiology and infectious diseases.
European primary care rapidly adapted during the COVID-19 pandemic by deciding how to transform care delivery, despite limited training and resources, reports the first pan European qualitative study in eight countries.
The coordination module of the EU-funded projects RECOVER1 and EU-RESPONSE2 has launched its website.